Revolution Medicines, Inc. Contracts & Agreements
58 Contracts & Agreements
- Business Finance (13 contracts)
- Business Operations (6)
- Human Resources (21)
- Mergers & Acquisitions (3)
- Real Estate (12)
- Uncategorized (3)
- Form of Pre-Funded Warrant (Filed With SEC on December 5, 2024)
- Underwriting Agreement, dated as of December 3, 2024, among Revolution Medicines, Inc. and J.P. Morgan Securities LLC, TD Securities (USA) LLC, Goldman Sachs & Co. LLC and... (Filed With SEC on December 5, 2024)
- Employment Agreement dated as of August 1, 2024 by and between Revolution Medicines, Inc. and Xiaolin Wang, Sc.D (Filed With SEC on November 6, 2024)
- Employment Agreement, dated as of August 1, 2024 by and between Revolution Medicines, Inc. and Jack Anders (Filed With SEC on November 6, 2024)
- Sixth Amendment, dated as of July 12, 2024, to Lease by and between HCP LS Redwood City, LLC and Revolution Medicines, Inc (Filed With SEC on November 6, 2024)
- REVOLUTION MEDICINES, INC. $500,000,000 SALES AGREEMENT (Filed With SEC on November 6, 2024)
- Employment Agreement dated as of August 1, 2024 by and between Revolution Medicines, Inc. and Xiaolin Wang, Sc.D (Filed With SEC on August 7, 2024)
- Employment Agreement, dated as of August 1, 2024 by and between Revolution Medicines, Inc. and Jack Anders (Filed With SEC on August 7, 2024)
- Sixth Amendment, dated as of July 12, 2024, to Lease by and between HCP LS Redwood City, LLC and Revolution Medicines, Inc (Filed With SEC on August 7, 2024)
- Sales Agreement, dated as of August 7, 2024, by and between Revolution Medicines, Inc. and TD Securities (USA), LLC (Filed With SEC on August 7, 2024)
- Non-Employee Director Compensation Program (Filed With SEC on May 8, 2024)
- Description of Securities (Filed With SEC on February 26, 2024)
- Agreement and Plan of Merger, dated August 5, 2021, by and among EQRx, Inc. (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx,... (Filed With SEC on February 26, 2024)
- Warrant Agreement, dated April 6, 2021, by and between Continental Stock Transfer & Trust Company and EQRx, Inc (Filed With SEC on February 26, 2024)
- Fifth Amendment to Lease and between HCP LS Redwood City, LLC and Revolution Medicines, Inc., dated as of August 3, 2023 (Filed With SEC on November 6, 2023)
- Form of Lock-up Agreement with Revolution Medicines, Inc (Filed With SEC on August 1, 2023)
- Form of Voting Agreement with Revolution Medicines, Inc (Filed With SEC on August 1, 2023)
- Agreement and Plan of Merger, dated July 31, 2023, by and among Revolution Medicines, Inc., EQRx, Inc., Equinox Merger Sub I, Inc. and Equinox Merger Sub II LLC (Filed With SEC on August 1, 2023)
- Underwriting Agreement, dated as of March 2, 2023, among Revolution Medicines, Inc. and J.P. Morgan Securities LLC, Cowen and Company, LLC, SVB Securities LLC and Guggenheim... (Filed With SEC on March 7, 2023)
- Underwriting Agreement, dated as of July 19, 2022, among Revolution Medicines, Inc. and J.P. Morgan Securities LLC, Cowen and Company, LLC and Guggenheim Securities, LLC, as... (Filed With SEC on July 22, 2022)
- First Amendment to Employment Agreement dated June 10, 2022 by and between Revolution Medicines, Inc. and Mark Goldsmith, M.D., Ph.D (Filed With SEC on June 10, 2022)
- Employment Agreement by and between Revolution Medicines, Inc. and Xiaolin Wang Sc.D (Filed With SEC on May 9, 2022)
- Employment Agreement by and between Revolution Medicines, Inc. and Jack Anders (Filed With SEC on May 9, 2022)
- Non-Employee Director Compensation Program (Filed With SEC on May 9, 2022)
- Description of Common Stock (Filed With SEC on February 28, 2022)
- THIRD AMENDMENT TO LEASE (Filed With SEC on November 10, 2021)
- Sales Agreement, dated November 10, 2011, by and between Revolution Medicines, Inc. and Cowen and Company, LLC (Filed With SEC on November 10, 2021)
- Non-Employee Director Compensation Program (Filed With SEC on August 11, 2021)
- Letter Agreement and Amendment, dated as of August 5, 2021 by and between Revolution Medicines, Inc. and Genzyme Corporation (Filed With SEC on August 11, 2021)
- Form of Underwriting Agreement (Filed With SEC on February 1, 2021)
- Non-Employee Director Compensation Program (Filed With SEC on July 6, 2020)
- Form of Underwriting Agreement (Filed With SEC on July 6, 2020)
- Second Amendment to Lease by and between HCP LS Redwood City, LLC and Revolution Medicines, Inc., dated as of April 17, 2020 (Filed With SEC on May 14, 2020)
- Description of Common Stock (Filed With SEC on March 30, 2020)
- 2020 Incentive Award Plan (Filed With SEC on February 3, 2020)
- Form of Stock Option Grant Notice and Stock Option Agreement under the 2020 Incentive Award Plan (Filed With SEC on February 3, 2020)
- Form of Restricted Stock Award Agreement under the 2020 Incentive Award Plan (Filed With SEC on February 3, 2020)
- Form of Restricted Stock Unit Award Grant Notice under the 2020 Incentive Award Plan (Filed With SEC on February 3, 2020)
- 2020 Employee Stock Purchase Plan (Filed With SEC on February 3, 2020)
- Non-Employee Director Compensation Program (Filed With SEC on February 3, 2020)
- Form of Indemnification Agreement for directors and officers (Filed With SEC on February 3, 2020)
- Agreement and Plan of Merger, dated as of October 15, 2018, by and among Revolution Medicines, Inc., Trotsky Merger Sub, Inc., Warp Drive Bio, Inc., and Fortis Advisors LLC (Filed With SEC on January 17, 2020)
- Sublease Agreement between Revolution Medicines, Inc., as successor to Warp Drive Bio, LLC, and Casma Therapeutics, Inc., dated as of February 4, 2019 (Filed With SEC on January 17, 2020)
- Sublease between OncoMed Pharmaceuticals, Inc. and Revolution Medicines, Inc., dated as of January 16, 2019 (Filed With SEC on January 17, 2020)
- Lease between HCP LS Redwood City, LLC and Revolution Medicines, Inc., dated as of January 15, 2015 (Filed With SEC on January 17, 2020)
- Employment Agreement by and between Revolution Medicines, Inc. and Margaret Horn, J.D (Filed With SEC on January 17, 2020)
- Employment Agreement by and between Revolution Medicines, Inc. and Steve Kelsey, M.D., FRCP, FRCPath (Filed With SEC on January 17, 2020)
- Employment Agreement by and between Revolution Medicines, Inc. and Mark A. Goldsmith, M.D., Ph.D (Filed With SEC on January 17, 2020)
- Form of Amended and Restated Early Exercise Stock Option Grant Notice and Amended and Restated Stock Option Agreement under 2014 Equity Incentive Plan, as amended (Filed With SEC on January 17, 2020)
- Form of Underwriting Agreement (Filed With SEC on January 17, 2020)
- 2014 Equity Incentive Plan, as amended (Filed With SEC on January 17, 2020)
- Form of Common Stock Certificate (Filed With SEC on January 17, 2020)
- Collaborative Research, Development and Commercialization Agreement, dated as of June 8, 2018, by and between Revolution Medicines, Inc. and Aventis, Inc., as amended (Filed With SEC on January 17, 2020)
- Amended and Restated Investors Rights Agreement, dated as of June 5, 2019, by and among Revolution Medicines, Inc. and the investors listed therein (Filed With SEC on January 17, 2020)
- First Amendment to Lease by and between HCP LS Redwood City, LLC and Revolution Medicines, Inc., dated as of September 16, 2016 (Filed With SEC on January 17, 2020)
- Lease Agreement between Are-Tech Square, LLC and Warp Drive Bio, LLC, dated as of August 22, 2012 (Filed With SEC on January 17, 2020)
- First Amendment to Lease by and between Are-Tech Square, LLC and Warp Drive Bio, Inc., dated as of May 18, 2017 (Filed With SEC on January 17, 2020)
- Assignment and Assumption of Lease by and between Warp Drive Bio, LLC and Revolution Medicines, Inc., dated as of January 30, 2019 (Filed With SEC on January 17, 2020)
